A Prospective Clinical Trial Designed to Evaluate the Repeatability and Reproducibility of the Intelon BOSS(tm) System
Prospective Clinical Trial Designed to Evaluate the Repeatability and Reproducibility of the Intelon BOSS(tm) System
1 other identifier
interventional
34
1 country
1
Brief Summary
This is a prospective, open-label, single-site clinical trial designed to evaluate the repeatability and reproducibility of biomechanical imaging by the updated version of the BOSS device. Subjects will undergo unilateral biomechanical mapping of the cornea and lens by three (3) BOSS devices operated by three (3) different operators.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 14, 2022
CompletedFirst Submitted
Initial submission to the registry
June 8, 2022
CompletedFirst Posted
Study publicly available on registry
June 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 13, 2022
CompletedMay 4, 2025
September 1, 2022
4 months
June 8, 2022
April 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Analysis of variance in BOSS analysis to determine repeatability and reproducibility
A random effect model will be used to assess variation due to device/operator configuration
30 days
Study Arms (1)
Biomechanical Imaging of the Eye
OTHERInterventions
Eligibility Criteria
You may qualify if:
- years or older
You may not qualify if:
- No light perception
- Any systemic disease or disorder which would prohibit image aquisition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vold Vision plc
Fayetteville, Arkansas, 72704, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2022
First Posted
June 21, 2022
Study Start
May 14, 2022
Primary Completion
September 13, 2022
Study Completion
September 13, 2022
Last Updated
May 4, 2025
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share